PAVmed, Inc. (PAVM)
5.16
-0.19
(-3.55%)
USD |
NASDAQ |
Sep 03, 16:00
5.16
0.00 (0.00%)
After-Hours: 20:00
PAVmed Research and Development Expense (Annual) : 4.492M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 4.492M |
| December 31, 2024 | 5.932M |
| December 31, 2023 | 14.28M |
| December 31, 2022 | 25.55M |
| December 31, 2021 | 19.85M |
| December 31, 2020 | 10.96M |
| Date | Value |
|---|---|
| December 31, 2019 | 6.630M |
| December 31, 2018 | 4.248M |
| December 31, 2017 | 2.619M |
| December 31, 2016 | 1.720M |
| December 31, 2015 | 0.4893M |
| December 31, 2014 | 0.011M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.27M |
| AtriCure, Inc. | 90.17M |
| Baxter International, Inc. | 503.00M |